Person

Karen S. Lynch

Director, Thermo Fisher Scientific

Current S&P 500 boards
2
Current roles
2
Open-market buys
$977K
Open-market sales
$6.0M

Current roles

From Section 16 filings (Forms 3, 4 and 5) in the last 13 months.

Past roles

“Last filing” is the latest Form 3/4/5 for that company, an upper bound on the end date.

Sits alongside

People who currently share a board or management team with this person.

Open-market trades

Purchases and sales reported on Form 4 at S&P 500 companies.

DateCompanyTypeSharesPriceValue
May 3, 2023CVSBuy14,000$69.75$977K
Nov 18, 2019CVSSale80,143$75.00$6.0M

SEC reporting-owner ID (CIK) 1333760 · all filings on EDGAR